Literature DB >> 23566662

New bone formation in axial spondyloarthritis.

Daniel Wendling1, Pascal Claudepierre.   

Abstract

New bone formation of the entheses with possible progression to ankylosis is among the hallmarks of axial spondyloarthritis. Radiographic scores are available for evaluating axial new bone formation. The complex systems that underlie new bone formation involve Wnt bone-formation signaling and the natural Wnt inhibitors DKK-1 and sclerostin, as well as growth factors such as the bone morphogenetic proteins (BMPs); these systems are modulated by proinflammatory cytokines, most notably TNF. Factors that predict progressive new bone formation include the presence of syndesmophytes, various biological markers (CRP, MMP-3, sclerostin, DKK-1, and BMP), smoking, and prior vertebral corner abnormalities (inflammation and, above all, resolved inflammation). Nonsteroidal antiinflammatory agents seem able to slow the pace of radiographic progression, an effect not documented to date with TNF antagonists in patients with axial spondyloarthritis.
Copyright © 2013 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Ankylosing spondylitis; Magnetic resonance imaging; New bone formation; Nonsteroidal antiinflammatory drugs; Radiography; Spondyloarthritis; Syndesmophyte; TNFα antagonists

Mesh:

Year:  2013        PMID: 23566662     DOI: 10.1016/j.jbspin.2013.02.004

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  7 in total

1.  Smoking and spondyloarthritis: a bad connection.

Authors:  Daniel Wendling; Clément Prati
Journal:  Rheumatol Int       Date:  2015-10-13       Impact factor: 2.631

2.  Comment on "treat-to-target in spondyloarthritis: implications for clinical trial designs".

Authors:  Daniel Wendling; Clément Prati
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

3.  Bushen-Qiangdu-Zhilv decoction inhibits osteogenic differentiation of rat fibroblasts by regulating connexin 43.

Authors:  Ying-Yan Zhou; Run-Yue Huang; Jie-Hua Lin; Yong-Yue Xu; Xiao-Hong He; Yi-Ting He
Journal:  Exp Ther Med       Date:  2016-04-26       Impact factor: 2.447

Review 4.  Bone Involvement in Patients with Spondyloarthropathies.

Authors:  Willem Lems; Corinne Miceli-Richard; Judith Haschka; Andrea Giusti; Gitte Lund Chistensen; Roland Kocijan; Nicolas Rosine; Niklas Rye Jørgensen; Gerolamo Bianchi; Christian Roux
Journal:  Calcif Tissue Int       Date:  2022-01-23       Impact factor: 4.333

5.  Characterization of individuals with sacroiliac joint bridging in a skeletal population: analysis of degenerative changes in spinal vertebrae.

Authors:  Takeshi Imamura; Kazunobu Saiki; Keishi Okamoto; Junichiro Maeda; Hiroaki Matsuo; Tetsuaki Wakebe; Keiko Ogami; Yoshitaka Manabe; Hironobu Koseki; Masato Tomita; Atsushi Tagami; Makoto Osaki; Hiroyuki Shindo; Toshiyuki Tsurumoto
Journal:  Biomed Res Int       Date:  2014-09-08       Impact factor: 3.411

6.  Serum from patients with ankylosing spondylitis can increase PPARD, fra-1, MMP7, OPG and RANKL expression in MG63 cells.

Authors:  Zaiying Hu; Dongfang Lin; Jun Qi; Minli Qiu; Qing Lv; Qiuxia Li; Zhiming Lin; Zetao Liao; Yunfeng Pan; Ou Jin; Yuqiong Wu; Jieruo Gu
Journal:  Clinics (Sao Paulo)       Date:  2015-11       Impact factor: 2.365

Review 7.  The Role of Imaging in Diagnosing Axial Spondyloarthritis.

Authors:  Nikita Khmelinskii; Andrea Regel; Xenofon Baraliakos
Journal:  Front Med (Lausanne)       Date:  2018-04-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.